Free Shipping on All Orders $75 Or More!

Your Trusted Brand for Over 35 Years

Daily News

Concerned Mother Says FDA Might Remove Drug Helping Teen Sons Fight Rare Disease



An experimental drug has been a life saver for two brothers in Chester County but the FDA might take it away.

Two teenage brothers have a rare genetic disease. Theyve been doing well with this experimental drug for years, but the FDA says theres not enough evidence it works.

Like most brothers, Elliott and Henry Johnson are competitive and love video games but the Downingtown brothers have trouble walking, so they usually rely on scooters. They have Duchenne muscular dystrophy, an incurable progressive disease.

You cant do other stuff your friends can do and stuff. And youre different and stuff like that, Elliott said.

Elliott was diagnosed first, ten years ago, and Henry received his diagnosis a month later.

It was the worst day of our life as parents, their mother, Joanna, said. The dreams you have for your children just go up in smoke. Youre lost. We were struggling to cope we didnt know what to do.

Joanna and her husband Paul were told their children with Duchenne would slowly lose their lives, but there was a ray of hope.

The doctor called us and said, I have the worst possible news but I have the best news in the worst possible case scenario and that theres a drug trial,` Joanna recalled.

The drug Ataluren claims to slow the progression of Duchenne. It quickly gave the Johnson brothers more mobility.

Its a life changer for them, Joanne said. It was like you were seeing a miracle in front of your eyes.

After school, every day, theyre in the backyard playing with their dog, but their fun days are now in jeopardy.

The FDA has rejected approval of the drug that keeps them moving. If the appeal fails, the drug will no longer be available.

Im terrified, Joanne said. Im absolutely terrified that all the benefits that were seeing are just going to go away, then were back to square one with no hope and no help, nowhere to go.

In rejecting the approval, the FDA said there wasnt enough evidence to prove the drug works.

I understand they (the FDA) want more data, Joanne said. I dont have time. The boys dont have time to wait. You have 12 years with no safety concerns whatsoever.

Because its a rare disease, the scope of the drug trial was limited and while it might not have worked for others, it did for these two brothers.

The FDA is expected to have a decision on the appeal around Christmas. The Johnsons are hoping they have something special to celebrate.

Articles featured in Life Extension Daily News are derived from a variety of news sources and are provided as a service by Life Extension. These articles, while of potential interest to readers of Life Extension Daily News, do not necessarily represent the opinions nor constitute the advice of Life Extension.